Barclays PLC Pds Biotechnology Corp Transaction History
Barclays PLC
- $327 Billion
- Q2 2024
A detailed history of Barclays PLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Barclays PLC holds 1 shares of PDSB stock, worth $3. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1
Previous 19,766
99.99%
Holding current value
$3
Previous $78,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding PDSB
# of Institutions
80Shares Held
5.47MCall Options Held
155KPut Options Held
61.7K-
Vanguard Group Inc Valley Forge, PA1.41MShares$4.75 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$1.64 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny381KShares$1.29 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA378KShares$1.27 Million0.0% of portfolio
-
Inspirion Wealth Advisors, LLC360KShares$1.21 Million0.16% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $95.9M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...